Immunization against angiotensins for the treatment of hypertension. by Maurer, P, Bachmann, M

Vaccination against nicotine: an emerging therapy for tobacco dependence. by Maurer, P, Bachmann, M

Suppressor cell induction in vitro. VI. Production of suppressor factors to synthetic polypeptides GAT and (T,G)-A--L from cells of responder and nonresponder mice. by Kontianen, S, Howie, S, Maurer, P, Feldmann, M

Triadic resonant instability in confined and unconfined axisymmetric geometries by Boury, S., Maurer, P., Joubaud, S., Peacock, T., Odier, P.

Get full text

In vitro studies on H-2 linked unresponsiveness. 1. Normal helper cells to (T,G)-A-L and GAT in low and non-responder mice. by Howie, S, Feldmann, M, Mozes, E, Maurer, P

INVITRO STUDIES ON H-2 LINKED UNRESPONSIVENESS .1. NORMAL HELPER CELLS TO (T,G)-A-L AND GAT IN LOW AND NON-RESPONDER MICE by Howie, S, Feldmann, M, Mozes, E, Maurer, P

COMPLEMENTATION OF H-2-LINKED IR GENES - USE OF HELPER FACTOR TO ANALYZE RESPONSES TO GLYPHE by Baltz, M, Maurer, P, Merryman, C, Feldmann, M

The role of monoclonal antibody affinity in mediating protection against autoimmune inflammatory diseases by Dallenbach, K, Maurer, P, Kopf, M, Bachmann, M

Dust mite allergy - New treatment options by Haug, S, Senti, G, Johansen, P, Maurer, P, Bachmann, M, Kuendig, T

Dust mite allergy - new treatment option by Haug, S, Senti, G, Johansen, P, Maurer, P, Bachmann, M, T, K

TLR9 signaling in B cells determines class switch recombination to IgG2a by Jegerlehner, A, Maurer, P, Bessa, J, Hinton, H, Kopf, M, Bachmann, M

Serological analysis of antigen-specific helper factors specific for poly-L(Tyr, Glu)-poly-DLAla--poly-LLys [(T, G)-A--L] and L Glu60-LAla30-LTyr10 (GAT). by Howie, S, Parish, C, David, C, McKenzie, I, Maurer, P, Feldmann, M

TLR9 signaling in B cells determines class switch recombination to IgG2a. by Jegerlehner, A, Maurer, P, Bessa, J, Hinton, H, Kopf, M, Bachmann, M

Different binding modes of free and carrier-protein-coupled nicotine in a human monoclonal antibody. by Tars, K, Kotelovica, S, Lipowsky, G, Bauer, M, Beerli, R, Bachmann, M, Maurer, P

Cytokine production by peripheral blood cells following therapy with a combined vaccine of allergen and QbG10 by Manolova, V, Flace, A, Maurer, P, Saudan, P, Senti, G, Kuendig, T, Bachmann, M

Isolation of human monoclonal antibodies by mammalian cell display. by Beerli, R, Bauer, M, Buser, R, Gwerder, M, Muntwiler, S, Maurer, P, Saudan, P, Bachmann, M

Protection against osteoporosis by active immunization with TRANCE/RANKL displayed on virus-like particles. by Spohn, G, Schwarz, K, Maurer, P, Illges, H, Rajasekaran, N, Choi, Y, Jennings, G, Bachmann, M

Virus-like particles as a modular system for novel vaccines. by Lechner, F, Jegerlehner, A, Tissot, A, Maurer, P, Sebbel, P, Renner, W, Jennings, G, Bachmann, M

CYT006-AngQb, a vaccine against hypertension targeting angiotensin II, reduces early-morning and day-time blood pressure by Tissot, A, Nussberger, J, Maurer, P, Stocker, H, Pfister, T, Wagner, F, Mueller, P, Jennings, G, Bachmann, M

Virus-like particles induce robust human T-helper cell responses. by Braun, M, Jandus, C, Maurer, P, Hammann-Haenni, A, Schwarz, K, Bachmann, M, Speiser, D, Romero, P